Ferumoxytol-Enhanced Cardiac Magnetic Resonance Angiography and 4D Flow: Safety and Utility in Pediatric and Adult Congenital Heart Disease is a research paper published in Children (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01HL127153
National Institutes of Health
Grant: R01HL148182
National Institutes of Health
Grant: I01CX001901
National Institutes of Health
Grant: I01CX002208
Veterans Health Administration
Grant: I01CX001901, I01CX002208
NIH HHS
Grant: R01HL127153, R01HL148182
National Institutes of Health
Grant: 5I01CX002208-03
Development of a practical quantitative non-contrast approach for cerebrovascular MRI
National Institutes of Health
Grant: 5I01CX001901-08
Tailoring Stress Cardiac MRI for Women with Ischemic Heart Disease
National Institutes of Health
Grant: 5R01HL148182-02
Ferumoxytol-Enhanced Cardiac MRI for Ischemic Heart Disease
National Institutes of Health
Grant: 5R01HL127153-09
Expanding on a new paradigm for MRI in pediatric congenital heart disease
FWCI
1.03
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals